A Comprehensive Approach for Brain Disorders: Traditional Renal Function Tests, Novel Biomarker Cystatin C, Advanced Imaging Techniques, Green Tea, and Erythropoietin

Abstract

This review explores the integration of traditional renal function tests with Cystatin C biomarkers and advanced imaging techniques for the early detection and prognosis of brain disorders. Additionally, the potential improvement in clinical outcomes through the combined use of green tea and erythropoietin is discussed. Key points of analysis include the limitations of traditional renal function tests, the role of Cystatin C biomarkers in enhancing diagnostic accuracy, the importance of advanced imaging techniques, and the need for a comprehensive approach to address brain disorders. The study employs a qualitative approach, utilizing clinical trial data, medical case studies, and peer-reviewed articles. Results highlight the limitations of traditional tests, the efficacy of integrating Cystatin C biomarker testing, and the potential benefits of advanced imaging. As a complementary empowerment of the therapy the combination of green tea and erythropoietin introduces a synergistic approach to neuroprotection. Green tea's anti-inflammatory and anti-oxidative effects may complement erythropoietin's neuroprotective mechanisms, potentially leading to enhanced outcomes in the context of brain disorders. While each substance alone has shown promise, their combination may offer a more robust and multifaceted approach to addressing the complex mechanisms involved in neurological pathologies. This study compares individual and integrated methods, emphasizing the importance of a comprehensive approach for improved diagnostic accuracy and patient outcomes. Limitations of the study and recommendations for future research are also presented.